Tin Alley Ventures

What Tin Alley Ventures does

Tin Alley Ventures is an Australian venture capital fund manager established in 2022 as a joint venture between the University of Melbourne and Tanarra Capital. The firm manages the A$125m Tin Alley Venture Fund No. 1, the first fund of its kind in Australia structured as a university-affiliated deep tech vehicle, and invests from seed to pre-IPO in companies with strong connections to the University of Melbourne ecosystem. Its primary disciplines are life sciences (biotechnology, pharmaceuticals, neurotechnology, biomedical) and physical sciences (materials science, quantum, climate tech), with the broader deep tech mandate covering software and hardware. As of the source date, the fund has executed nine investments out of 200+ spinouts reviewed, including Synchron (neurotechnology), Cell Bauhaus (bioprocessing), Porous Lane (climate tech), Apromore (acquired by Salesforce in 2025), Neurala Biosciences, exteRNA, Proxima Bio, Gallant Bio, and i14/Intelligent Silicon.

The firm's core operating platform is its privileged University of Melbourne origination channel, anchored at the Melbourne Connect co-working hub at Carlton. The firm differentiates through a Founder-In-Residence programme that pairs commercially-trained operators with academic founders to develop research IP into investible companies from the ideation stage. The investment team comprises Managing Partner Dr Andrew McLean (formerly Oxford Science Enterprises), three Investment Managers (Michelle He, Calum McConville, Tim Kay), and four Founders-in-Residence. Investment Committee oversight is provided by Dr Arjun Goyal (Vida Ventures, US$1.7bn+ AUM), Ken Jefferd (UM Commercialisation), John Wylie AC (Tanarra, A$3.5bn+ AUM), Dr David Llewellyn (former CEO DJS Antibodies), and Shilpi Sharma (former CEO Kvantum). Capital deployment ranges from A$500,000 to A$5m+ per company, with 100+ global experts and syndicate investors providing downstream co-investment capacity.

Revenue is generated through conventional VC fund economics: management fees on the A$125m fund and carried interest on portfolio exits. Investors (LPs) in the fund include the University of Melbourne, distinguished alumni, family offices, institutional investors, and Breakthrough Victoria, with Tanarra Capital Australia Pty Ltd serving as the AFSL holder for Tin Alley Ventures Pty Ltd. The fund co-invests with the Genesis Pre-Seed Fund to capture opportunities at earlier stages. Geographic focus is domestic (Melbourne / Parkville Biomedical Precinct) with a global mandate for portfolio scaling; there is no public product, software platform, or SaaS offering — all activity is investment-led.

Name

Tin Alley Ventures

Legal name

Tin Alley Ventures Pty Ltd

Website

https://www.tinalleyventures.com/

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Tin Alley Ventures is an Australian venture capital fund manager that operates the A$125m Tin Alley Venture Fund No. 1, investing from seed to pre-IPO in deep tech and life sciences startups spun out of the University of Melbourne ecosystem.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

All Other Financial Investment Activities (52399), Other Financial Investment Activities (5239)

SIC

Investment Advice (6282)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Venture capital fund
• Deep tech investing
• University spinouts
• Research commercialization
• Seed stage investing

Headquarters

HQ city

Carlton

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel

Revenue model

1. Venture Capital Fund Management: Tin Alley Ventures generates returns through managing the Tin Alley Venture Fund No. 1, a A$125m fund investing in deep tech startups. Revenue comes from management fees and carried interest on successful portfolio exits.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Tin Alley Ventures is an A$125m venture capital fund that invests in deep tech startups affiliated with the University of Melbourne, from seed to pre-IPO stages. Primary disciplines are life sciences and physical sciences, with the fund supporting portfolio companies via its Founder-In-Residence Program and access to 100+ global experts and syndicate investors. The fund has made 9 investments out of 200+ University spinouts reviewed since its founding in 2022.

Product overview

Tin Alley Ventures is not a product or technology company — it is a venture capital fund. The firm operates as an A$125m investment fund managed by Tin Alley Ventures Pty Ltd, a joint venture between the University of Melbourne and Tanarra Capital. The fund invests in deep tech spinouts from the Seed to pre-IPO stage across life sciences, hardware, software, and climate tech sectors. The fund's investment mandate focuses on companies with strong connections to the University of Melbourne ecosystem, providing capital and operational support to research commercialization ventures. No standalone software product, platform, SaaS offering, or API product is offered by the firm — all intelligence pertains to the investment fund and its portfolio of 9 invested companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Tin Alley Venture Fund No. 1
• Founder-In-Residence Program

Quantifiable outcome

• Of 200+ University spinouts reviewed, 9 investments made
• +2 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core.

• University of MelbournecoreStrategic or Co-development Partner · 1 January 2022University of Melbourne is a joint venture partner in Tin Alley Ventures, created in partnership between the University and Tanarra Capital. The University is an investor in Tin Alley Ventures' first fund and provides privileged access to research intellectual property, researchers, students, and alumni for investment opportunities. Tin Alley Ventures serves as the University's dedicated vehicle for venture capital investment.
• Tanarra CapitalcoreStrategic or Co-development Partner · 1 January 2022Tanarra Capital is a joint venture partner with the University of Melbourne in Tin Alley Ventures. Tanarra Capital Australia Pty Ltd (ABN 88 114 164 331; AFSL 290098) is the AFSL holder for Tin Alley Ventures Pty Ltd. John Wylie AC is founder and CEO of Tanarra with A$3.5bn+ AUM and serves on the Investment Committee.
• Melbourne ConnectcoreStrategic or Co-development PartnerTin Alley Ventures is located at Melbourne Connect, a co-working and innovation hub that is part of the University of Melbourne's research and innovation ecosystem. Melbourne Connect houses startups, researchers, and innovation programs.
• Melbourne Biomedical Precinct PartnerscoreStrategic or Co-development PartnerTin Alley Ventures leverages the Melbourne Biomedical Precinct ecosystem which includes Melbourne Connect, Florey Institute, Jumar Bioincubator, Walter and Eliza Hall Institute (WEHI), Doherty Institute, Peter MacCallum Cancer Centre, Fishermans Bend Innovation Precinct, St Vincent's Institute, The Royal Women's Hospital, Murdoch Children's Research Institute, and The Royal Children's Hospital Melbourne. The precinct has 40+ hospitals, medical research institutes and biomedical organisations with 8,500+ researchers.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Main Sequence Ventures: Australian deep tech VC founded in 2017 with privileged access to CSIRO research IP, investing in spinouts across life sciences, agri-food, space, and advanced manufacturing. Closest direct peer — same university/research-institute-backed deep tech model in Australia.
• Uniseed: Australia's longest-running research commercialisation fund, backed by University of Melbourne, University of Queensland, and University of NSW. Direct competitor for university-linked deep tech deal flow and co-investment partner in several Australian university ecosystems.
• Oxford Science Enterprises: UK-based deep tech investor founded as a partnership with the University of Oxford, with $1bn+ under management investing across life sciences, physical sciences, and AI. Tin Alley's Managing Partner Dr Andrew McLean was part of the founding team — same playbook applied to the University of Melbourne ecosystem.
• IP Group plc: UK-listed IP commercialisation company that partners with leading research universities (Oxford, Cambridge, Imperial, etc.) to spin out deep tech and life sciences companies. The most established global model of university-linked research commercialisation venture capital.
• Brandon Capital Partners: Australian life sciences VC manager of the Medical Research Commercialisation Fund, backed by AustralianSuper, Statewide Super, and major medical research institutes. Direct competitor for Australian life sciences deals and a likely co-investment partner given overlapping mandates.
• Cambridge Innovation Capital: UK-based deep tech and life sciences investor partnering with the University of Cambridge, MRC, and other research institutions. Operates the same university-linked research commercialisation model as Tin Alley, with a comparable life sciences and physical sciences mandate.

Broad incumbents

• Blackbird Ventures: One of Australia's largest and most prominent venture capital firms, focused on early-stage technology companies. Overlaps with Tin Alley's software investments (e.g., i14) but operates as a generalist rather than deep tech or university-linked specialist.
• Square Peg Capital: Australia- and Israel-focused venture capital firm with A$2bn+ under management, investing in technology and technology-enabled businesses. Broader stage range and sector mandate than Tin Alley's research-focused deep tech approach.
• AirTree Ventures: Australian venture capital firm investing across technology, software, and consumer businesses from seed to growth stages. Generalist model with broader sector and stage mandate than Tin Alley's deep tech / life sciences specialisation.

Others

• Breakthrough Victoria: Victorian state government-backed innovation fund that has invested in Tin Alley Venture Fund No. 1 and other Victorian deep tech ventures. Functions as a financial partner and ecosystem co-investor rather than a competing manager.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments8 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tin Alley Ventures